| Date Checked | 2026-02-19 22:18:23 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | 2018-09-14 |
| Symbol | ALT |
| AssetType | Common Stock |
| Name | Altimmune Inc |
| Description | Altimmune, Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, dedicated to developing innovative intranasal vaccines and immunomodulatory therapies to meet significant unmet medical needs. Leveraging its proprietary technology platforms, Altimmune is advancing a diverse pipeline targeting infectious diseases and liver disorders, with a focus on providing transformative solutions in these high-impact areas. The company's strong commitment to research and development, combined with its expertise, positions it favorably to achieve breakthroughs that can enhance patient care and strengthen its competitive stance in the dynamic biopharmaceutical industry. |
| CIK | 1326190 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 910 CLOPPER ROAD, GAITHERSBURG, MD, UNITED STATES, 20878 |
| OfficialSite | https://altimmune.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 437195000 |
| EBITDA | -90343000 |
| PERatio | 0 |
| PEGRatio | 0 |
| BookValue | 1.941 |
| DividendPerShare | None |
| EPS | -1.07 |
| RevenuePerShareTTM | 0 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -4171.8 |
| ReturnOnAssetsTTM | -0.309 |
| ReturnOnEquityTTM | -0.526 |
| RevenueTTM | 20000 |
| GrossProfitTTM | -67784000 |
| DilutedEPSTTM | -1.07 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | 0 |
| AnalystTargetPrice | 17.75 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 5 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 21859.73 |
| PriceToBookRatio | 2.356 |
| EVToRevenue | 12116.18 |
| EVToEBITDA | -4.2 |
| Beta | 0.03 |
| 52WeekHigh | 7.73 |
| 52WeekLow | 2.9 |
| 50DayMovingAverage | 4.47 |
| 200DayMovingAverage | 4.562 |
| SharesOutstanding | 104342000 |
| SharesFloat | 103561000 |
| PercentInsiders | 0.641 |
| PercentInstitutions | 40.224 |
| ExDividendDate | 2017-01-20 |
| dateChecked | 2026-02-19 22:18:23 |
| fresh | 1 |